Showing results (251-260 of 294) with videos related to

Sort By:
Pageof 30
Digestion|July 19, 2000
Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infectionT Konrad, S Zeuzem, G Toffolo, et al.
Journal of Viral Hepatitis|January 14, 2012
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysisM Friedrich-Rust, J Nierhoff, M Lupsor, et al.
Journal of Hepatology|March 9, 2000
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis BV Carreño, S Zeuzem, U Hopf, et al.
European Journal of Clinical Investigation|January 29, 2000
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alphaT Konrad, S Zeuzem, P Vicini, et al.
Journal of Clinical Microbiology|September 28, 2007
Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite studyG Colucci, J Ferguson, C Harkleroad, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2009
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodulesM Friedrich-Rust, A Sperber, K Holzer, et al.
Journal of Viral Hepatitis|June 28, 2016
Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV typeB Fülöp, U Mihm, P Rohde, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 30, 1999
Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver diseaseT Konrad, P Vicini, S Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|September 26, 2002
Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancerJ Raedle, M Schaffner, N Esser, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Pageof 30